To further investigate the functionality of the p53 pathway in CLL cells of TC animals that had relapsed following four cycles of cyclophosphamide, we performed immunohistochemistry to assess the induction of the bona fide p53 target gene p21. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.